Compounds > 3-(1-azepanylsulfonyl)-n-(3-bromphenyl)benzamide

3-(1-azepanylsulfonyl)-n-(3-bromphenyl)benzamide and Reperfusion-Injury

3-(1-azepanylsulfonyl)-n-(3-bromphenyl)benzamide has been researched along with Reperfusion-Injury* in 1 studies

Other Studies

1 other study(ies) available for 3-(1-azepanylsulfonyl)-n-(3-bromphenyl)benzamide and Reperfusion-Injury

Article	Year
Neuroprotective Effect of Sirt2-specific Inhibitor AK-7 Against Acute Cerebral Ischemia is P38 Activation-dependent in Mice. Neuroscience, 2018, 03-15, Volume: 374 Cerebral ischemia is the most common cause of stroke with high morbidity, disability and mortality. Sirtuin-2 (Sirt2), a vitally important NAD Topics: Animals; Benzamides; Brain; Brain Ischemia; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Imidazoles; Male; Mice, Inbred ICR; Motor Activity; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Random Allocation; Reperfusion Injury; Sirtuin 2; Stroke; Sulfonamides	2018

Article

Year

Neuroprotective Effect of Sirt2-specific Inhibitor AK-7 Against Acute Cerebral Ischemia is P38 Activation-dependent in Mice.

Neuroscience, 2018, 03-15, Volume: 374

Cerebral ischemia is the most common cause of stroke with high morbidity, disability and mortality. Sirtuin-2 (Sirt2), a vitally important NAD

Topics: Animals; Benzamides; Brain; Brain Ischemia; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Imidazoles; Male; Mice, Inbred ICR; Motor Activity; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Random Allocation; Reperfusion Injury; Sirtuin 2; Stroke; Sulfonamides

2018